Cargando…
Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response
Head and neck squamous cell carcinomas (HNSCC) represent a group of epithelial neoplasms that exhibit considerable heterogeneity in clinical behavior. Here, we examined the stromal and vascular heterogeneity in a panel of patient-derived xenograft (PDX) models of HNSCC and the impact on therapeutic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679003/ https://www.ncbi.nlm.nih.gov/pubmed/31284584 http://dx.doi.org/10.3390/cancers11070951 |
_version_ | 1783441236379566080 |
---|---|
author | Folaron, Margaret Merzianu, Mihai Duvvuri, Umamaheswar Ferris, Robert L. Seshadri, Mukund |
author_facet | Folaron, Margaret Merzianu, Mihai Duvvuri, Umamaheswar Ferris, Robert L. Seshadri, Mukund |
author_sort | Folaron, Margaret |
collection | PubMed |
description | Head and neck squamous cell carcinomas (HNSCC) represent a group of epithelial neoplasms that exhibit considerable heterogeneity in clinical behavior. Here, we examined the stromal and vascular heterogeneity in a panel of patient-derived xenograft (PDX) models of HNSCC and the impact on therapeutic response. Tumor sections from established tumors were stained for p16 (surrogate for human papillomavirus (HPV) infection), stromal (Masson’s trichrome) and vascular (CD31) markers. All PDX models retained the HPV/p16 status of the original patient tumor. Immunohistochemical evaluation revealed the presence of multiple vessel phenotypes (tumor, stromal or mixed) in the PDX panel. Vascular phenotypes identified in the PDX models were validated in a tissue microarray of human HNSCC. Treatment with a microtubule targeted vascular disrupting agent (VDA) resulted in a heterogeneous antivascular and antitumor response in PDX models. The PDX with the tumor vessel phenotype that exhibited higher CD31+ vessel counts and leaky vasculature on magnetic resonance imaging (MRI) was sensitive to VDA treatment while the PDX with the stromal vessel phenotype was resistant to therapy. Collectively, our results demonstrate the phenotypic and functional vascular heterogeneity in HNSCC and highlight the impact of this heterogeneity on response to antivascular therapy in PDX models of HNSCC. |
format | Online Article Text |
id | pubmed-6679003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66790032019-08-19 Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response Folaron, Margaret Merzianu, Mihai Duvvuri, Umamaheswar Ferris, Robert L. Seshadri, Mukund Cancers (Basel) Article Head and neck squamous cell carcinomas (HNSCC) represent a group of epithelial neoplasms that exhibit considerable heterogeneity in clinical behavior. Here, we examined the stromal and vascular heterogeneity in a panel of patient-derived xenograft (PDX) models of HNSCC and the impact on therapeutic response. Tumor sections from established tumors were stained for p16 (surrogate for human papillomavirus (HPV) infection), stromal (Masson’s trichrome) and vascular (CD31) markers. All PDX models retained the HPV/p16 status of the original patient tumor. Immunohistochemical evaluation revealed the presence of multiple vessel phenotypes (tumor, stromal or mixed) in the PDX panel. Vascular phenotypes identified in the PDX models were validated in a tissue microarray of human HNSCC. Treatment with a microtubule targeted vascular disrupting agent (VDA) resulted in a heterogeneous antivascular and antitumor response in PDX models. The PDX with the tumor vessel phenotype that exhibited higher CD31+ vessel counts and leaky vasculature on magnetic resonance imaging (MRI) was sensitive to VDA treatment while the PDX with the stromal vessel phenotype was resistant to therapy. Collectively, our results demonstrate the phenotypic and functional vascular heterogeneity in HNSCC and highlight the impact of this heterogeneity on response to antivascular therapy in PDX models of HNSCC. MDPI 2019-07-06 /pmc/articles/PMC6679003/ /pubmed/31284584 http://dx.doi.org/10.3390/cancers11070951 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Folaron, Margaret Merzianu, Mihai Duvvuri, Umamaheswar Ferris, Robert L. Seshadri, Mukund Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response |
title | Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response |
title_full | Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response |
title_fullStr | Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response |
title_full_unstemmed | Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response |
title_short | Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response |
title_sort | profiling the stromal and vascular heterogeneity in patient-derived xenograft models of head and neck cancer: impact on therapeutic response |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679003/ https://www.ncbi.nlm.nih.gov/pubmed/31284584 http://dx.doi.org/10.3390/cancers11070951 |
work_keys_str_mv | AT folaronmargaret profilingthestromalandvascularheterogeneityinpatientderivedxenograftmodelsofheadandneckcancerimpactontherapeuticresponse AT merzianumihai profilingthestromalandvascularheterogeneityinpatientderivedxenograftmodelsofheadandneckcancerimpactontherapeuticresponse AT duvvuriumamaheswar profilingthestromalandvascularheterogeneityinpatientderivedxenograftmodelsofheadandneckcancerimpactontherapeuticresponse AT ferrisrobertl profilingthestromalandvascularheterogeneityinpatientderivedxenograftmodelsofheadandneckcancerimpactontherapeuticresponse AT seshadrimukund profilingthestromalandvascularheterogeneityinpatientderivedxenograftmodelsofheadandneckcancerimpactontherapeuticresponse |